UNITY Biotechnology Inc (NASDAQ:UBX)

0.88
Delayed Data
As of 3:58pm ET
 -0.15 / -14.56%
Today’s Change
0.55
Today|||52-Week Range
3.84
-39.73%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$60.0M

Company Description

Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.

Contact Information

Unity Biotechnology, Inc.
285 East Grand Avenue
South San Francisco California 94080
P:(650) 416-1192
Investor Relations:

Employees

Shareholders

Mutual fund holders5.01%
Individual stakeholders18.80%
Other institutional12.64%

Top Executives

Anirvan GhoshChief Executive Officer & Director
Nathan GuzVice President-Operations
Lynne SullivanChief Financial Officer
Jamie DananbergChief Medical Officer
Susan Lundeen SmuckChief Human Resources Officer